Different modes of inhibition of mouse Cyp2a5 and rat CYP2A3 by the food-derived 8-methoxypsoralen

Food and Chemical Toxicology

Volumn 46, Issue 3, 2008, Pages 1190-1195

  Visoni, S ^a   Meireles, N ^a   Monteiro, L ^a   Rossini, A ^a   Pinto, L F R ^a  

^a Inst Biol Roberto Alcantara Gomes   (Brazil)

Author keywords

8 Methoxypsoralen; Chemoprevention; Coumarin 7 hydroxylase; CYP2A3; Cyp2a5

Indexed keywords

COUMARIN 7 HYDROXYLASE; CYTOCHROME P450; CYTOCHROME P450 2A3; CYTOCHROME P450 2A5; METHOXSALEN; UNCLASSIFIED DRUG;

ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NONHUMAN; RAT;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ENZYME INHIBITORS; KINETICS; MALE; METHOXSALEN; MICE; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; RATS; RATS, WISTAR;

NICOTIANA TABACUM; RATTUS;

EID: 38649091964     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.12.001     Document Type: Article

References (40)

1. Aitio A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal. Biochem. 85 (1978) 488-491
2. Béréziat J., Raffalli F., Schmezer P., Frei E., Geneste O., and Lang M.A. Cytochrome P4502A of nasal epithelium: regulation and role in carcinogen metabolism. Mol. Carcinog. 14 (1995) 130-139
3. Camus A., Geneste O., Honkakoski P., Béréziat J., Henderson C., Wolf C., Bartsch H., and Lang M.A. High variability of nitrosamine metabolism among individuals: role of Cytochrome P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol. Carcinog. 7 (1993) 268-275
4. Crespi C., Penman B., Leakey J., Arlotto M., Stark A., Parkinson A., Turner T., Steimel D., Rudo K., Davies R., and Langenbach R. Human cytochrome P450 IIA3: cDNA sequence, role of the enzyme in metabolic activation of promutagens, comparison to nitrosamine activation by cytochrome P450 IIEI. Carcinogenesis 11 (1990) 1293-1300
5. Damaj M.I., Siu E., Sellers E.M., Tyndale R., and Martin B. Inhibition of nicotine metabolism by methoxysalen: pharmacokinetic and pharmacological studies in mice. J. Pharmacol. Exp. Ther. 320 (2007) 250-257
6. Draper A.J., Madan A., and Parkinson A. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys. 341 (1997) 47-61
7. Felicia N., Rekha G.K., and Murphy S.E. Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism. Arch. Biochem. Biophys. 384 (2000) 418-424
8. Fukuhara M., Mizokami K., Sakaguchi M., Niimura Y., Kato K., Inouye S., and Takanaka A. Aflatoxin B1-specific cytochrome P450 isozyme (P450-AFB) inducible by 3-methylcholantrene in golden hamsters. Biochem. Pharmacol. 39 (1990) 463-469
9. Fukuhara M., Kurose K., Aida N., Matsunaga N., Omata W., Kato K., and Kimura M. A major phenobarbital-inducible P450 isozyme, CYP2A14, in the Chinese hamster liver: purification, characterization, and cDNA cloning. Arch. Biochem. Biophys. 359 (1998) 241-248
10. Godoy W., Albano R.M., Moraes E., Pinho P., Nunes R., Saito E., Higa C., Filho I., Kruel C., Schirmer C.C., Gurski R., Lang M.A., and Ribeiro Pinto L.F. CYP2A6/2A7 and CYP2E1 expression in human esophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 23 (2002) 611-616
11. Gonzalez F.J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 40 (1988) 243-288
12. Honkakoski P., Kojo A., Raunio H., Pasanen M., Juvonen R., and Lang M.A. Hepatic mitochondrial coumarin 7-hydroxylase: comparison with the microsomal enzyme. Arch. Biochem. Biophys. 267 (1988) 558-567
13. Honkakoski P., Mäenpää J., Leikola J., Pasanen M., Juvonen R., Lang M.A., Pelkonen O., and Raunio H. Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung. Pharmacol. Toxicol. 72 (1993) 107-112
14. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemical to Man, Some Naturally Occurring Substances (1976), IARC, Lyon
15. Juvonen R., Shkumatov V., and Lang M.A. Purification and characterization of a liver microsomal P450 isoenzyme with high affinity and metabolic capacity for coumarin from pyrazole treated D2 mice. Eur. J. Biochem. 171 (1988) 205-211
16. Kimura S., Kozak C.A., and Gonzalez F.J. Identification of a novel P450 expressed in rat lung: cDNA cloning and sequence, chromosome mapping, and induction by 3-methylcholanthrene. Biochemistry 28 (1989) 3798-3803
17. Koenigs L.L., Peter R., Thompson S.J., Rettie A., and Trager W. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab. Dispos. 25 (1997) 1407-1415
18. Koskela S., Hakkola J., Hukkanen J., Pelkonen O., Sorri M., Saranen A., Antilla S., Fernandez-Salguero P., Gonzalez F., and Haunio H. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol. 57 (1999) 1407-1413
19. Lang M.A., and Pelkonen O. Metabolism of xenobiotics and chemical carcinogenesis. IARC Scientific Publications 148 (1999) 13-22
20. Lewis D.F.V. Guide to Cytochromes P450, Structure and Function (2001), Taylor & Francis, London
21. Lewis D.F., and Lake B.G. Species differences in coumarin metabolism: a molecular modeling evaluation of CYP2A interactions. Xenobiotica 32 (2002) 547-561
22. Lijinsky W. The Chemistry and Biology of N-nitroso Compounds (1992), Cambridge University Press, Cambridge
23. Lindberg R.L.P., and Negishi M. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino acid residue. Nature 339 (1989) 632-634
24. Lowry O.H., Rosebrough N., Farr A.L., and Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
25. Mäenpää J., Sigusch H., Raunio H., Syngelmä T., Vuorela P., Vuorela H., and Pelkonen O. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem. Pharmacol. 45 (1993) 1035-1042
26. Mäenpää J., Juvonen R., Raunio H., Rautio A., and Pelkonen O. Metabolic interactions of methoxsalen and coumarin in humans and mice. Biochem. Pharmacol. 48 (1994) 1363-1369
27. Miyazaki M., Yamazaki H., Takeuchi H., Saoo K., Yokohira M., Masumura K., Nohmi T., Funae Y., Imaida K., and Kamataki T. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas. Carcinogenesis 26 (2005) 1947-1955
28. Parkinson A. Biotransformation of Xenobiotics. In: Klaassen C.D. (Ed). Casarret & Doulĺs Toxicology (1996), McGraw-Hill, New York
29. Patten C.J., Peterson L.A., and Murphy S.E. Evidence for metabolic activation of N′-nitrosonornicotine and N′-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase. Drug Metab. Dispos. 26 (1998) 177-180
30. Pelkonen P., Lang M.A., and Pasanen M. Tissue and sex-dependent differences in CYP2A activities in hamsters. Arch. Toxicol. 68 (1994) 416-422
31. Pelkonen P., Lang M.A., Wild C.P., Negishi M., and Juvonen R.O. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells. Eur. J. Pharmacol. 292 (1994) 67-73
32. Peng H., Ding X., and Coon M. Isolation and heterologous expression of cloned cDNAs for two rabbit nasal microsomal proteins, CYP2A10 and CYP2A11, that are related to nasal microsomal cytochrome P450 form a. J. Biol. Chem. 268 (1993) 17253-17260
33. Raunio H., Syngelmä T., Pasanen M., Juvonen R., Honkakoski P., Kairaluoma M., Sotaniemi E., Lang M.A., and Pelkonen O. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem. Pharmacol. 37 (1988) 3889-3895
34. Ribeiro Pinto L.F., Moraes E., Albano R., Silva M.C., Godoy W., Glisovic T., and Lang M.A. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis. Carcinogenesis 22 (2001) 1877-1883
35. Robottom-Ferreira A.B., Aquino S.R., Queiroga R., Albano R.M., and Ribeiro Pinto L.F. Expression of CYP2A3 mRNA and its regulation by 3-methylcholanthrene, pyrazole, and β-ionone in rat tissues. Braz. J. Med. Biol. Res. 36 (2003) 839-844
36. Sellers E.M., Ramamoorthy Y., Zeman M.V., Djordjevic M.V., and Tyndale R. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo. Nicotine Tob. Res. 5 (2003) 891-899
37. Sellers E.M., Tyndale R., and Fernandes L. Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discov. Today 8 (2003) 487-493
38. Su T., Sheng J.J., Lipinskas T.W., and Ding X. Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab. Dispos. 24 (1996) 884-890
39. Takeuchi H., Saoo K., Yokohira M., Ikeda M., Maeta H., Miyazaki M., Yamazaki H., Kamataki T., and Imaida K. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res. 63 (2003) 7581-7583
40. von Weymarn L.B., Zhang Q., Ding X., and Hollenberg P.F. Effects of 8-methoxypsoralen on cytochrome P450 2A13. Carcinogenesis 26 (2005) 621-629